hsa-miR-218-5p

ncRNA information

ncRNA name

hsa-miR-218-5p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PRKDC

Cancer information

Cancer name

Lung Cancer

Cancer site

None

Treatment information

Treatment type

Radiotherapy

Impact of wild-type ncRNA on radiotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

miRNA-218-5p increases cell sensitivity by inhibiting PRKDC activity in radiation-resistant lung carcinoma cells

Tissue resource

peripheral blood samples from patients with non-small cell lung cancer who received radiotherapy

human embryonic kidney cell lines 293T

lung carcinoma cell lines A549

lung carcinoma cell lines H1299

lung carcinoma cell lines HCC827

lung carcinoma cell lines BEAS-2B

Experiment

None


Institute

the Shanghai Chest Hospital, Shanghai Jiao Tong University

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian